Inflammation during malaria is a determinant for the progression of plasmodial infection that
causes health burdens in humans. Emergence of parasite resistance, absence of dual
antiplasmodial and anti-inflammatory ...
Depression is a debilitating neurological illness characterised by behavioural and neurochemical changes.
Conventional antidepressants have poor efficacy, serious side effects and primarily target monoaminergic
systems, ...
Post-stroke Epilepsy (PSE) has been identified as a significant clinical
condition in stroke survivors affecting outcome, quality of life, and hospital
cost. They are clinically underestimated without consensus for ...
Hypoxic stress is known to induce depression, cognitive dysfunction and anxiety-related
complications through the activation of oxidative and inflammatory signaling pathways. Thus,
inhibition of these pathways might ...
Hypertension is a chronic cardiovascular disease characterised by persistent, elevated arterial blood pressure. High cost and adverse effect burden of current antihypertensive therapies necessitate the need for alternative ...
Acute Myocardial Infarction (AMI) is a leading cause of death associated with Heart Failure (HF) worldwide. Oxidative stress, inflammation and apoptosis are important underlying pathogenesis of AMI, which are not target ...
Misdiagnosis of malaria exposes patients to drug pressure which may contribute to the emergence of anti-malarial drug resistance. The WHO recommends the use of malaria Rapid Diagnostic Tests (mRDTs) to improve malaria ...
Olax subscorpioidea is used in the management of mental illness, fever and pain in ethnomedicine. However, there is scanty information on the neuropharmacological activities that supports its use. The study was designed ...